| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5697733 | Clinical Oncology | 2017 | 7 Pages |
Abstract
ART use is controversial in bladder cancer, yet unexpectedly has commonly been used among US radiation oncologists treating patients with MIBC after radical cystectomy. NRG-GU001 was a randomised trial in the US randomizing patients with high-risk pathological findings for observation or ART after cystectomy. However, due to poor accrual it recently closed and thus it will be up to other international trials to clarify the role of ART and identify patients benefiting form this adjuvant therapy.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Oncology
Authors
A.A. Solanki, B. Martin, M. Korpics, C. Small, M.M. Harkenrider, T. Mitin,